EI
CPRX

EAM Investors’s Catalyst Pharmaceutical CPRX Stock Holding History

EAM Investors’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-138,698
Closed -$3.36M – 256
2025
Q1 		$3.36M Buy
138,698
+4,574
+3% +$103K 0.58% 75
2024
Q4 		$2.8M Sell
134,124
-27,125
-17% -$583K 0.4% 128
2024
Q3 		$3.21M Buy
+161,249
New +$2.99M 0.48% 112
2023
Q1 		– Sell
-148,261
Closed -$2.76M – 277
2022
Q4 		$2.76M Sell
148,261
-33,538
-18% -$516K 0.57% 49
2022
Q3 		$2.33M Sell
181,799
-158,143
-47% -$1.87M 0.51% 72
2022
Q2 		$2.38M Sell
339,942
-25,473
-7% -$187K 0.58% 51
2022
Q1 		$3.03M Buy
365,415
+126,344
+53% +$893K 0.56% 47
2021
Q4 		$1.62M Buy
+239,071
New +$1.57M 0.27% 174
2019
Q2 		– Sell
-498,844
Closed -$2.54M – 261
2019
Q1 		$2.54M Buy
+498,844
New +$1.47M 0.62% 40
2018
Q1 		– Sell
-790,872
Closed -$3.09M – 299
2017
Q4 		$3.09M Buy
+790,872
New +$2.61M 0.55% 44
2015
Q4 		– Sell
-60,858
Closed -$183K – 320
2015
Q3 		$183K Sell
60,858
-170,193
-74% -$735K 0.03% 290
2015
Q2 		$954K Sell
231,051
-1,125
-0.5% -$4.48K 0.11% 296
2015
Q1 		$1M Buy
+232,176
New +$837K 0.12% 301
2013
Q4 		– Sell
-446,957
Closed -$1.36M – 317
2013
Q3 		$1.36M Buy
+446,957
New +$752K 0.27% 141

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EAM Investors's CPRX Position: Q2 2025 in Review

EAM Investors sold out of Catalyst Pharmaceutical (CPRX) in Q2 2025, closing a stake of 138,698 shares — an estimated $3.36M sold.

EAM Investors first reported a position in CPRX in Q3 2013 and held it in 14 quarters. The position peaked at $3.36M in Q1 2025. 365 funds tracked by Wall St. Rank hold CPRX as of Q2 2025.

  • EAM Investors reported no remaining Catalyst Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • EAM Investors sold 138,698 Catalyst Pharmaceutical shares in Q2 2025, an estimated $3.36M.
  • EAM Investors first reported a position in Catalyst Pharmaceutical in Q3 2013 and held it in 14 quarters.
  • EAM Investors's Catalyst Pharmaceutical position peaked at $3.36M in Q1 2025.
  • 365 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2025.

Based on EAM Investors's 13F filing for Q2 2025, filed 12 Aug 2025.